Invest in health & biotech startups from £25

Health & biotech startups are among the most talked-about early-stage opportunities, and on Savvy Mango you can back them from as little as £25. Every company here releases your money in stages, only as it hits real milestones, so you fund progress, not promises.

Why investors back health & biotech startups

Health and biotech startups target huge markets, from diagnostics to therapeutics. Horizons are long, but the potential impact and upside are significant. On Savvy Mango you can take part from £25 and own a real, proportional share, rather than needing the thousands a traditional angel deal once required.

How your money is protected

Capital is released to each business in stages, only as it proves real, verified milestones, with spending checked against genuine invoices. You fund proven progress, not promises. Investing is still high risk and you could lose what you put in.

Building a sensible health & biotech portfolio

No one can reliably pick winners, so many investors spread small amounts across several health & biotech startups and other sectors. Fractional ownership from £25 makes that practical, and where companies are EIS or SEIS eligible, some may qualify for UK tax relief. Holdings are not always locked until a company exits. Through Savvy Mango's private secondary market you can request to sell early, subject to a willing buyer.

2 opportunities open now

Money released by progress

Businesses are funded in stages, only as they prove real, verified milestones.

Watch what you fund

Follow companies and property builds with real updates, photos and footage.

From just £25

Fractional ownership means anyone can start small and spread across opportunities.

Questions & answers

How much do I need to invest in health & biotech startups?

You can start from £25 and spread it across several companies to reduce risk.

How is my money protected?

Money is released in stages as each company proves verified progress, and spending is checked against real invoices. Investing is still high risk and you could lose what you put in.

Can I sell before the company exits?

Where a buyer is available, you can request to sell early on Savvy Mango's private secondary market.

Explore more

Get alerts for health & biotech startups

We'll email you the moment a matching new opportunity launches. Unsubscribe any time.

By joining you agree to receive occasional emails about new investments. No spam, unsubscribe any time.

Start from £25 today.

Back real companies and real buildings, and only ever fund proven progress.